{"url_path":"/sec/apge/8-k/2026-06-22/item-8-01","section_key":"item-8-01","section_title":"Item 8.01 Other Events.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1974640/0001140361-26-025844-index.html","accession_number":"0001140361-26-025844","cik":"0001974640","ticker":"APGE","issuer_name":"Apogee Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1974640/0001140361-26-025844-index.html","primary_entity_key":"0001974640","primary_entity_name":"Apogee Therapeutics, Inc."},"word_count":127,"has_tables":true,"body_markdown":"Item 8.01\n\nOther Events.\n\n \n\nVoting Agreement\n\n \n\nConcurrently with the execution and delivery of the Merger Agreement, Parent, Merger Sub and Guarantor entered into a voting agreement (the\n“Voting Agreement”) with certain stockholders of the Company, whereby such stockholders have agreed, among other things, to vote their Shares in favor of the adoption of the Merger Agreement and approval of the Merger. The Voting Agreement will\nterminate upon termination of the Merger Agreement and certain other specified events.\n\n \n\n The foregoing description of the Voting Agreement does not purport to be complete, and is subject to, and qualified in its entirety by reference\nto, the full text of the Voting Agreement, which is filed as Exhibit 99.2 to this Current Report on Form 8-K and incorporated herein by reference."}